Literature DB >> 21057902

Ivabradine in heart failure: to SHIFT or not to SHIFT.

Andres Schuster1, W H Wilson Tang.   

Abstract

Entities:  

Year:  2011        PMID: 21057902     DOI: 10.1007/s11897-010-0036-2

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


× No keyword cloud information.
  11 in total

1.  Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.

Authors:  Finlay A McAlister; Natasha Wiebe; Justin A Ezekowitz; Alexander A Leung; Paul W Armstrong
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

2.  Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

Authors:  P Lechat; J S Hulot; S Escolano; A Mallet; A Leizorovicz; M Werhlen-Grandjean; G Pochmalicki; H Dargie
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

3.  Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.

Authors:  Marco Metra; Christian Torp-Pedersen; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Beatrix Lutiger; Armin Scherhag; Mary Ann Lukas; Andrew Charlesworth; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-07-21       Impact factor: 29.983

4.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

Authors:  K D Aaronson; J S Schwartz; T M Chen; K L Wong; J E Goin; D M Mancini
Journal:  Circulation       Date:  1997-06-17       Impact factor: 29.690

5.  What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

Authors:  Lars Gullestad; John Wikstrand; Prakash Deedwania; Ake Hjalmarson; Kenneth Egstrup; Uri Elkayam; Stephen Gottlieb; Andrew Rashkow; Hans Wedel; Georgina Bermann; John Kjekshus
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

6.  Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

Authors:  P Lechat; S Escolano; J L Golmard; H Lardoux; S Witchitz; J A Henneman; B Maisch; M Hetzel; P Jaillon; J P Boissel; A Mallet
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

7.  The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes.

Authors:  Puneeta Tandon; Finlay A McAlister; Ross T Tsuyuki; Marilou Hervas-Malo; Ruth Dupuit; Justin Ezekowitz; Bibiana Cujec; Paul W Armstrong
Journal:  Arch Intern Med       Date:  2004-04-12

8.  The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

Authors:  M Komajda; F Follath; K Swedberg; J Cleland; J C Aguilar; A Cohen-Solal; R Dietz; A Gavazzi; W H Van Gilst; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; J Widimsky; N Freemantle; J Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

10.  The properties of the pacemaker current I(F)in human ventricular myocytes are modulated by cardiac disease.

Authors:  E Cerbai; L Sartiani; P DePaoli; R Pino; M Maccherini; F Bizzarri; F DiCiolla; G Davoli; G Sani; A Mugelli
Journal:  J Mol Cell Cardiol       Date:  2001-03       Impact factor: 5.000

View more
  2 in total

Review 1.  Is Heart Rate a Norepiphenomenon in Heart Failure?

Authors:  Mark Hensey; James O'Neill
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

2.  Effect of ivabradine on endothelial function in diastolic and right heart failure patients.

Authors:  Arturo Orea-Tejeda; Karla Balderas-Muñoz; Lilia Castillo-Martínez; Oscar Infante-Vázquez; Raúl Martínez Memije; Candace Keirns-Davis; Joel Dorantes-García; René Narváez-David; Zuilma Vázquez-Ortíz
Journal:  Cardiol Res Pract       Date:  2013-10-03       Impact factor: 1.866

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.